D-0758-2026 Class III Ongoing

Recalled by Supernus Pharmaceuticals, Inc. — Rockville, MD

FDA drug recall D-0758-2026 was initiated by Supernus Pharmaceuticals, Inc. on Jul 6, 2026 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is ongoing. Affected quantity: 15,853 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 6, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,853 bottles

Product description

Trokendi XR, topiramate extended-release capsules, 25mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-101-30.

Reason for recall

Failed Dissolution Specifications

Distribution pattern

US Nationwide.

Code information

Lot # 2075801, Exp Date: 31-Oct-2029.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0758-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0758-2026. Report a data issue: hello@regdatalab.com.